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ABSTRACT
Aflatoxin B1 (AFB1), aflatoxin M1 (AFM1), and ochratoxin A (OTA) that may lead to severe problems in children’s health
were evaluated in commonly consumed various types of baby foods. In the present study, 63 infant formulae, follow on formulae
and baby foods were randomly collected from pharmacies and supermarkets in Ankara, Turkey. AFB1, AFM1, and OTA levels
were assessed by commercially available enzyme-linked immunosorbent assay (ELISA) kits. AFB1, AFM1 and OTA levels were
found in 87, 36.5 and 40% of the samples between 0.10-6.04 ppb, 0.06-0.32 ppb and 0.27-4.50 ppb, respectively. We suggest that
mycotoxin contamination should be routinely monitored in foods for babies in order to reduce food-borne hazards in infants and
young children.
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INTRODUCTION
Mycotoxins are food contaminants produced by
certain kinds of fungi and the most commonly found
mycotoxins, namely af latoxins and ochratoxins, carry
potential risks for humans(1-2). Aflatoxins are highly toxic
and carcinogenic secondary metabolites produced by
Aspergillus flavus, A. parasiticus and A. nomius in various
foodstuffs(1-6). A. flavus produces only aflatoxin B (AFB1
+ AFB2), while the other two species produce both aflatoxin B and G (AFG1 + AFG2)(6). Activation of aflatoxin
B1 is important in any mycotoxicological consideration of
the effects of AFB1 on organisms. AFB1 itself is not carcinogenic, but is metabolized into an ultimate carcinogenic
metabolite by oxidation of an 8,9-vinyl ether bond, and
this epoxide form binds to nucleic acids and proteins (1).
AFB1 is listed as a Group 1 agent by the International
Agency for Research on Cancer (IARC), especially as
a cause of hepatocellular carcinoma (2,7). Af latoxin M1
(AFM1) is the hydroxylated metabolite of AFB1, found in
the milk of humans and animals(1,4). They may be found
in milk products obtained from livestock that have ingested contaminated feed (3-6). The toxic and carcinogenic
effects of AFB1 have been convincingly demonstrated in
laboratory animals and AFM1 is classified as a Group 2B
human carcinogen (3-4) though its carcinogenic potency
in sensitive species is estimated to be approximately 10
times lower than that of AFB1(5). In some animals, weight
loss, anorexia, hemorrhage, renal damage, gastrointestinal
and urogenital carcinomas have been associated with the
effects of aflatoxins(1-2).
On the other hand, ochratoxin A (OTA) is found in
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many commodities, including cereals, cereal products,
coffee, grapes, grape juice, wine, cocoa, beer, meat,
milk and milk products (2,8-10). OTA is mainly produced
by Penicillium verrusocum in temperate climates and
by a number of Aspergillus spp. such as A. ochraceus,
A. carbonarius, A. niger and A. terreus in warmer and
tropical areas(8-9). OTA is classified as a possible human
carcinogen (Group 2B) by IARC due to its nephrotoxic
effects (10). Renal function and morphology are greatly
affected by at high dose of OTA, as indicated by increased
kidney weight, urine volume, blood urea nitrogen, urinary
glucose and proteinuria. Changes in renal enzymes and
protein patterns can be used to distinguish the type of
renal injury caused by OTA(2,6). OTA is also associated
with Balkan Endemic Nephropathy (BEN), which is a
fatal human kidney disease(2,6), and it is a potent immunotoxin, genotoxin, mutagen and teratogen(9).
The susceptibility of infants and young children
towards the adverse effects of mycotoxins is higher than
that of adults so that these types of contaminations in baby
foods should seriously be taken into concern. Contamination of infant formulae and baby foods is inevitable since
multiple ingredients are present in infant formulae and
baby foods, including milk powder, fruits or different
kinds of cereals. Therefore the major aim of the present
study was to assess AFB1, AFM1 and OTA levels in infant
formulae, follow-on formulae and baby foods.

MATERIALS AND METHODS
I. Samples
Sixty three powered infant for mulae, follow on
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II. Methods of Analysis
The samples were screened for AFB1, AFM1 and
OTA contents by commercial AFB1, AFM1 and OTA
en z y me-lin ked im mu nosorbent assay (ELISA) kits
(Ridascreen®, R-Biopharm AG, Darmstadt, Germany),
respectively. All chemicals used in the experiments were
of analytical grade.
According to the instructions of the manufacturer,
for the deter mination of AFB1, 2 g powered sample
was mixed with 3 mL phosphate-saline buffer (PBS)
and 0.2 mL amylase solution, and extracted with 7 mL
methanol (100%, v/v). The entire sample solution was
filtered through folded paper filter. Two milliliters of the
filtrate was mixed with two milliliters distilled water and
extracted with 3 mL dichloromethane. The organic layer
was evaporated with weak nitrogen stream. The dry
residue was dissolved in 1 mL methanol, and then 1 mL
distilled water and 1.5 mL n-heptane were added. After
the extraction, 100 µL methanol layer was diluted with
400 µL of test sample dilution buffer and 50 µL of this
was applied on the AFB1 test plate.
In order to determine the AFM1 contamination of the
samples, 2 g of each powered sample was extracted with
20 mL methanol: water (70:30) using a shaker at room
temperature. After centrifugation, upper cream layer was
completely removed by aspirating using a pasteur pipette.
One hundred microliter skimmed portion was directly
applied on the AFM1 test plate.
Determination of OTA by ELISA, according to OTA
test procedure, was performed by adding 2.5 mL of 1 N
HCl on 2 g of each powered sample, shaking at room
temperature and later extracting with 4 mL dichloromethane. The dichloromethane phase was collected and
mixed with 2 mL of 0.13 M sodium bicarbonate, pH: 8.1.
Aqueous phase was collected and diluted with 1 mL of the
buffer, and 50 µL of this was used for the OTA test.
The optical densities were measured at 450 nm by
using an ELISA 96-well microplate reader (Sunrise Gmblt,
Tecan, Austria). The linear standard curves for AFB1,
AFM1 and OTA are shown in Figure 1.
Mycotoxi n cont a m i nat ion i n each sa mple was
expressed as parts per billion (ppb). The lower detection limits for AFB1, AFM1 and OTA by ELISA were
0.025, 0.050 and 0.025 ppb, respectively. Sample, which
contained the mycotoxins under the limit mentioned
above, was accepted as a negative contamination. The
recovery ratios for AFB1, AFM1, and OTA kit assays
were 68% with a mean coefficient of variation (CV) 18%,
95% with a mean CV 15%, and 85% with a mean CV
14%, respectively.

RESULTS AND DISCUSSION
ELISA as a screening method is used quickly to
detect mycotoxin levels in foods(4,6-7), and the result gives
crude ideas concerning the mycotoxin contamination.
The commercial baby foods and processed milk- and/
or cereal-based foods for infants and young children in the
study were collected from supermarkets and pharmacies in
Ankara, but they are also distributed to all areas in Turkey.
Therefore, the results might give ideas about the contamination profile of aflatoxin B1, aflatoxin M1 and ochratoxin
A for these infant formula and baby food in Turkey. Data
on the occurrence and presence of mycotoxin in foods and
feeds are needed to estimate a possible exposure degree
and also to establish the regulatory limits.
As shown in Table 1, the incidence of AFB1 contamination in these infant formulae and baby foods was very
high, since 55 (87%) samples contained AFB1 above the
detection limit, 0.025 ppb and were considered positive
contamination. However, eight samples with AFB1 over
the permissible level of 1 ppb were accepted for infant
formulae and baby foods in Turkey. The average AFB1
level was found as 0.89 ± 1.10 ppb in 55 samples. The
detected levels were at 0.10 ppb in minimum and 6.04
ppb in maximum. Using a similar approach by Beretta et
al.(8), the risk of AFB1 intake from baby foods can be estimated. If a 5-month-old child with a body weight of 6.5
kg can consume 26 g of formula per portion, according to
the manufacturer’s suggestion, with the highest quantity
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Figure 1. Samples of the ELISA linear standard curves of the AFB1
(---), AFM1 (– ) and OTA (…).

Table 1. Occurrence of af latoxin B1 in baby foods and infants
formulae
Contamination level, ppb
Frequency distribution,
n (%)

AFB1
Sample

Average

≤0.025

>0.025

Mean ± SD

Milk-based, n = 29

2 ( 7)

27 (93)

0.73 ± 1.11

Cereal-based, n = 25

3 (12)

22 (88)

0.80 ± 0.44

Milk + cereal-based, n = 9

3 (33)

6 (67)

1.93 ± 2.08

Total (n = 63)

8 (13)

55 (87)

0.89 ± 1.10
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of AFB1 detected (6.04 ppb or µg/kg), 24.16 ng AFB1/kg
b.w. would be taken at a time. AFB1 is the most potent
carcinogen known in mammals, the risk assessment of
which is very well established.
The levels of aflatoxin M1 in 24 samples were higher
than 0.05 ppb, accepted as permission limit in Turkey,
as shown in Table 2. This value is equal to the detection
limit for AFM1 in the study. Aflatoxin M1 was detected
at low levels (≤ 0.05 ppb) in 63.5% of the infant formulae
and baby foods, and between levels 0.06 and 0.32 ppb
in 36.5% of the samples. With a similar calculation to
AFB1 mentioned above, a child with body weight of 6.5
kg would uptake the maximum 1.23 ng AFM1/kg b.w. at
a time. Since AFM1 is a genotoxic carcinogen, the risks
against infants and young children from AFM1 exposure
need careful consideration(5).
According to the European Commission(11), the maximum level of ochratoxin A in baby foods and processed
cereal-based foods for infants and young children was
0.5 ppb. Since OTA limit was not established in the same
foods in our country, the Commission Regulation(11) was
considered as the guide in the study. Twenty five samples
were found contaminated with OTA, and the OTA levels
in 19 among these samples exceeded the permission
level (Table 3). The detected minimum level of OTA in
the tested samples was 0.27 ppb while 4.50 ppb was the
maximum. According to the instructions on the label, a
baby consumes 25 g of formula per portion. If a 5-monthold child with body weight of 6.5 kg and infant formula
with the highest quantity of ochratoxin A found (4.50 ppb
Table 2. Occurrence of af latoxin M1 in baby foods and infants
formulae
Contamination level, ppb
Frequency
distribution, n (%)

AFM1
Sample

≤0.050

>0.050

Average
Mean ± SD

Milk-based, n = 29

16 (55)

13 (45)

0.06 ± 0.03

Cereal-based, n = 25

19 (76)

2 6 (24)

0.06 ± 0.03

Milk+cereal-based, n = 9

45 (56)

2 4 (44)

0.18 ± 0.09

Total (n = 63)

40 (63.5)

23 (36.5)

0.07 ± 0.05

Table 3. Occurrence of ochratoxin A in baby foods and infants
formulae
Contamination level, ppb
Frequency
distribution, n (%)

OTA
Sample

≤0.025

Average

>0.025

Mean ± SD

Milk-based, n = 29

22 (76) 2 7 (24)

0.50 ± 0.33

Cereal-based, n = 25

11 (44)

14 (56)

1.82 ± 1.54

2 5 (56) 2 4 (44)

2.38 ± 1.22

Milk+cereal-based, n = 9
Total (n = 63)

38 (60)

25 (40)

1.54 ± 1.40

or µg/kg) were considered, the maximum portion intake
would be 17.30 ng OTA per body weight (kg). The provisional tolerable weekly intake (PTWI) is 0.1 µg/kg b.w. for
ochratoxin A(12) so that there is a mild toxicological risk
for a child that consumes a formula with OTA contamination slightly above the permitted level. On the other
hand, considering these results, it could be concluded that
mycotoxin incidence in samples selected from commonly
consumed in Turkey, is not a serious public health problem
at the moment. However, the total daily mycotoxin intake
with the other sources of mycotoxin could be an important
risk for infants and young children.
Our results showed that some samples studied were
contaminated with AFB1, AFM1 and OTA. This situation might cause serious health problems in infants and
babies such as poor growth, suppressed immune system,
and cancer. An accurate prediction of the possible health
impact of individual mycotoxins in foods for the vulnerable
group is difficult; possible additive and synergistic effects
of multiple mycotoxins make the task even more complex
and the long-term effects are beyond foresight. Therefore
infant foods must be routinely tested for the mycotoxins
presence at every step of manufacturing and marketing.
Climatic and environ mental conditions du r ing
growth, harvest and storage have great influence on mycotoxin levels, which are probably also reflected in the levels
in feedstuffs (2,6,10). Since it is difficult to remove the
mycotoxin once formed, the best way of control is prevention. However, many measures have been to minimize the
occurrence of moulds such as alternative methods of soil
cultivation, development of mould resistant species and
drying and storage techniques(6).
We suggest that manufacturers of foods for infants
and young children should give an extreme importance
to mycotoxin content. We believe that manufacturers,
pediatricians, health-care personnel and parents should
be provided with enough information and training to
minimize health hazards and to form the public policies.
In order to protect public health, it is essential to keep
contaminants at levels toxicologically acceptable. Ultimately, surveillance should be continuous, widespread
and must be conducted by the government and related
ministries as the quality of the end product depend on the
precise controlling at every step of the production.
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